Mild disease does not lead to substantial long term illness in most infected individuals, say researchers Most symptoms or conditions that develop after mild covid-19 infection linger for several months but return to normal within a year, finds a large study from Israel published by The BMJ today. In particular, ...

Findings show small increased risk after adenovirus vaccines Should be considered when planning further immunisation campaigns and future vaccine development A study published by The BMJ today sheds further light on the risk of developing a very rare blood-clotting condition known as thrombosis with thrombocytopenia syndrome (TTS) after vaccination against ...

“A shocking situation linked to a lethal combination of intimate partner violence and firearms,” say experts Women in the US are more likely to be murdered during pregnancy or soon after childbirth than to die from the three leading obstetric causes of maternal death (high blood pressure disorders, hemorrhage, or ...

Number of cases low and predominantly mild Young males at highest risk shortly after second dose, suggesting longer dosing intervals might be beneficial Findings must be considered alongside overall benefits of vaccination A study published by The BMJ today provides an up to date summary of evidence on the risk ...

Risk higher for patients with underlying conditions and more severe covid-19 A study from Sweden published by The BMJ today finds an increased risk of deep vein thrombosis (a blood clot in the leg) up to three months after covid-19 infection, pulmonary embolism (a blood clot in the lung) up ...

Results confirm that protection wanes with time and suggest a third (booster) dose might be warranted A study published by The BMJ today finds a gradual increase in the risk of covid-19 infection from 90 days after receiving a second dose of the Pfizer-BioNTech vaccine. The study was carried out ...